Purchase Order 75N93025P00240
Award Date
2/6/25
Potential Completion Date
2/5/26
Potential Value
$16K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price purchase order to Illumina, Inc. for a MiSeq Silver Support Plan. The contract is valued at $15,575.00 and has a completion date of March 25, 2025. Illumina, a for-profit manufacturer of genomic sequencing instruments and reagents, has previously provided sequencing systems and consumables to support research and diagnostics...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of sequencing and array-based solutions. The $13,250.00 contract is for a MiSeq Silver Support Plan, with a completion date of September 25, 2020. Illumina has previously received prime federal contracts from agencies like the NIH, CDC, USDA, and VA to provide a range of sequencing systems,...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract provides a MiSeq Silver Support Plan with a ceiling value of $13,250.00 and an ultimate completion date of January 2, 2021. Illumina has a long history of providing sequencing systems and related products and services to support research and diagnostics across...
This is a firm fixed price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the prime contractor Illumina, Inc. for the purchase of MiSeq sequencing kits. The order, valued at $13,071, does not have a set-aside designation. Illumina is a for-profit manufacturer and provider of genetic sequencing and analysis instruments and reagents. The award supports NIAID's genomic research and diagnostics...
This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. for the purchase of a MiSeq System sequencing platform. The contract has a ceiling value of $95,931.00 and a completion date of August 21, 2014. Illumina is a manufacturer of sequencing and genomic analysis instruments and reagents that has previously provided such products and services to various federal...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genetic sequencing systems and analytical instruments. The $7,902 contract is for comprehensive service and support for Illumina's MiSeq gene and small genome sequencer. The award has no set-aside designation and is not associated with a larger contract vehicle. Illumina has been awarded...
This is a $119,060.18 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc. for the provision of an MISEQ2 sequencing instrument and associated reagents. The contract has no set-aside designation. Illumina, a manufacturer of genetic analysis instruments and reagents, has been awarded multiple prior federal contracts and sub-grants to provide...
The Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases awarded a firm fixed price contract to Illumina, Inc., a for-profit manufacturer of sequencing and array-based solutions, to provide a MiSeq Silver Support Plan. The contract, which has a potential value of $15,575.00, does not have a set-aside designation and is set to be completed by February 4, 2025. Illumina has previously been awarded prime federal contracts by...
This is a firm fixed price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genomic sequencing systems and reagents. The $129,931.28 contract is for the purchase of Illumina's MiSeq Reagent Kit V3, a sequencing consumable, without any set-aside designation. Illumina has previously received other prime federal contracts and sub-awards from agencies like the CDC,...
This is a $84,332.60 firm fixed price purchase order contract awarded by the Office of Acquisitions and Grants, a civilian agency, to Illumina, Inc. for a MiSeq Silver Support Plan. The contract has an ultimate completion date of August 14, 2026 and was awarded on August 15, 2020. This award does not have a set-aside designation. Illumina, a manufacturer of sequencing and array-based solutions, has previously received federal contracts and subcontracts from agencies like NIH, CDC, USDA, and VA...